Nakano H - Search Results

1

Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.

Tanaka Y, Miyamoto S, Suzuki SO, Oki E, Yagi H, Sonoda K, Yamazaki A, Mizushima H, Maehara Y, Mekada E, Nakano H. Tanaka Y, et al. Among authors: nakano h. Clin Cancer Res. 2005 Jul 1;11(13):4783-92. doi: 10.1158/1078-0432.CCR-04-1426. Clin Cancer Res. 2005. PMID: 16000575

2

ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma.

Ohishi Y, Oda Y, Uchiumi T, Kobayashi H, Hirakawa T, Miyamoto S, Kinukawa N, Nakano H, Kuwano M, Tsuneyoshi M. Ohishi Y, et al. Among authors: nakano h. Clin Cancer Res. 2002 Dec;8(12):3767-75. Clin Cancer Res. 2002. PMID: 12473588

3

Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer.

Fujita T, Miyamoto S, Onoyama I, Sonoda K, Mekada E, Nakano H. Fujita T, et al. Among authors: nakano h. Cancer Lett. 2003 Mar 31;192(2):161-9. doi: 10.1016/s0304-3835(02)00713-9. Cancer Lett. 2003. PMID: 12668280

4

Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.

Miyamoto S, Hirata M, Yamazaki A, Kageyama T, Hasuwa H, Mizushima H, Tanaka Y, Yagi H, Sonoda K, Kai M, Kanoh H, Nakano H, Mekada E. Miyamoto S, et al. Among authors: nakano h. Cancer Res. 2004 Aug 15;64(16):5720-7. doi: 10.1158/0008-5472.CAN-04-0811. Cancer Res. 2004. PMID: 15313912

5

Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer.

Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H. Sonoda K, et al. Among authors: nakano h. Gynecol Oncol. 2005 Jun;97(3):772-9. doi: 10.1016/j.ygyno.2005.02.025. Epub 2005 Apr 15. Gynecol Oncol. 2005. PMID: 15943986

6

Invasive potency related to RCAS1 expression in uterine cervical cancer.

Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H. Sonoda K, et al. Among authors: nakano h. Gynecol Oncol. 2005 Oct;99(1):189-98. doi: 10.1016/j.ygyno.2005.06.061. Gynecol Oncol. 2005. PMID: 16112176

7

Clinical significance of RCAS1 as a biomarker of uterine cancer.

Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H. Sonoda K, et al. Among authors: nakano h. Gynecol Oncol. 2006 Dec;103(3):924-31. doi: 10.1016/j.ygyno.2006.05.047. Epub 2006 Jul 13. Gynecol Oncol. 2006. PMID: 16842844

8

Clinical significance of RCAS1 as a biomarker of ovarian cancer.

Sonoda K, Miyamoto S, Yotsumoto F, Yagi H, Nakashima M, Watanabe T, Nakano H. Sonoda K, et al. Among authors: nakano h. Oncol Rep. 2007 Mar;17(3):623-8. Oncol Rep. 2007. PMID: 17273743

9

Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line.

Fukushima K, Miyamoto S, Tsukimori K, Kobayashi H, Seki H, Takeda S, Kensuke E, Ohtani K, Shibuya M, Nakano H. Fukushima K, et al. Among authors: nakano h. Biol Reprod. 2005 Jul;73(1):172-9. doi: 10.1095/biolreprod.104.039479. Epub 2005 Mar 23. Biol Reprod. 2005. PMID: 15788755

10

Expression of RCAS1 in female genital organs.

Kawano Y, Kaku T, Sonoda K, Hirakawa T, Kobayashi H, Ohishi Y, Nakano H. Kawano Y, et al. Among authors: nakano h. Int J Gynecol Pathol. 2005 Oct;24(4):330-4. doi: 10.1097/01.pgp.0000165204.37574.a5. Int J Gynecol Pathol. 2005. PMID: 16175077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,767 results

Search Page

Filters